piracetam has been researched along with Peripheral Nervous System Diseases in 5 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Based on the experience with carbamazepine, gabapentin, and lamotrigine, these newer AEDs are being investigated for the management of neuropathic pain." | 8.82 | Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. ( Guay, DR, 2003) |
| " Based on the experience with carbamazepine, gabapentin, and lamotrigine, these newer AEDs are being investigated for the management of neuropathic pain." | 4.82 | Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain. ( Guay, DR, 2003) |
| "Levetiracetam is an AED with unique mechanisms of action that may have analgesic properties in various pain syndromes." | 1.33 | Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary. ( Dunteman, ED, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardid, D | 1 |
| Lamberty, Y | 1 |
| Alloui, A | 1 |
| Coudore-Civiale, MA | 1 |
| Klitgaard, H | 1 |
| Eschalier, A | 1 |
| Ilag, VL | 1 |
| Guay, DR | 1 |
| Dunteman, ED | 1 |
| Niss, AI | 1 |
| Trubkovich, MIa | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Placebo-Controlled Crossover Trial of Levetiracetam on Ethanol Intake[NCT01168687] | 46 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome of this study is to determine the effect of levetiracetam on alcohol consumption as measured by change in # of drinks during each treatment period. (NCT01168687)
Timeframe: During each 14 day treatment period
| Intervention | number of drinks per treatment period (Mean) |
|---|---|
| All Subjects (n = 46) Placebo | 41.2 |
| All Subjects (n = 46) Levetiracetam | 45.4 |
1 review available for piracetam and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.
Topics: Aged; Analgesics, Non-Narcotic; Animals; Carbamazepine; Clinical Trials as Topic; Dose-Response Rela | 2003 |
4 other studies available for piracetam and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats.
Topics: Acute Disease; Analgesics; Animals; Carbamazepine; Chronic Disease; Constriction, Pathologic; Diabet | 2003 |
Future Pain Drugs - Europe 2003. 15-16 September 2003, London, UK.
Topics: Acetaminophen; Acetates; Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Disease Models, A | 2003 |
Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
Topics: Adult; Aged; Analgesics, Opioid; Anticonvulsants; Brachial Plexus Neuropathies; Dose-Response Relati | 2005 |
[Various rarely encountered adverse effects and complications of psychopharmacotherapy].
Topics: Adult; Agnosia; Amitriptyline; Apraxias; Brain Diseases; Cerebral Cortex; Haloperidol; Humans; Male; | 1985 |